Filed: 8/14/2024ACC: 0001420506-24-001501
📋 What this filing means
GHOST TREE CAPITAL, LLC filed this quarterly 13F‑HR report disclosing 60 equity positions with a total reported market value of $319.34M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
60
Positions
$319.34M
Total AUM (reported)
21.75M
Total Shares
Allocation by class
COM$221.33M69.3%
COM NEW$32.18M10.1%
COM PAR $.01$17.75M5.6%
CLASS A ORD$13.19M4.1%
SPONSORED ADR$11.83M3.7%
SHS$11.57M3.6%
COM CL A$3.36M1.1%
Portfolio Concentration
Top 3$56.85M17.8%
4–10$81.98M25.7%
11–25$105.36M33.0%
Rest$75.15M23.5%
Top 3 weight
17.8%
Top 10 weight
43.5%
Voting Authority Distribution
Total shares with voting rights: 21.75M
Sole
Full voting authority
21.75M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole60
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings60
Rows:
ALNYLAM PHARMACEUTICALS INC
SOLEShares90.90K
TypeSH
Market value$22.09M
6.92%
Sole
90.90K
Shared
0.00
None
0.00
INSMED INC
SOLEShares265K
TypeSH
Market value$17.75M
5.56%
Sole
265K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares490K
TypeSH
Market value$17.01M
5.33%
Sole
490K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares300K
TypeSH
Market value$13.19M
4.13%
Sole
300K
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares300K
TypeSH
Market value$12.24M
3.83%
Sole
300K
Shared
0.00
None
0.00
AXSOME THERAPEUTICS INC
SOLEShares150K
TypeSH
Market value$12.07M
3.78%
Sole
150K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares86.72K
TypeSH
Market value$11.83M
3.70%
Sole
86.72K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares150K
TypeSH
Market value$11.33M
3.55%
Sole
150K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares240K
TypeSH
Market value$10.75M
3.37%
Sole
240K
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares1M
TypeSH
Market value$10.57M
3.31%
Sole
1M
Shared
0.00
None
0.00
PERSPECTIVE THERAPEUTICS INC
SOLEShares925K
TypeSH
Market value$9.22M
2.89%
Sole
925K
Shared
0.00
None
0.00
TG THERAPEUTICS INC
SOLEShares500K
TypeSH
Market value$8.89M
2.79%
Sole
500K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares55K
TypeSH
Market value$8.69M
2.72%
Sole
55K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares260K
TypeSH
Market value$8.21M
2.57%
Sole
260K
Shared
0.00
None
0.00
CORBUS PHARMACEUTICALS HLDGS
SOLEShares175K
TypeSH
Market value$7.92M
2.48%
Sole
175K
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares587.71K
TypeSH
Market value$7.65M
2.39%
Sole
587.71K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares350K
TypeSH
Market value$7.19M
2.25%
Sole
350K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares260K
TypeSH
Market value$6.86M
2.15%
Sole
260K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares235K
TypeSH
Market value$6.39M
2.00%
Sole
235K
Shared
0.00
None
0.00
PHATHOM PHARMACEUTICALS INC
SOLEShares600K
TypeSH
Market value$6.18M
1.94%
Sole
600K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares1.42M
TypeSH
Market value$6.11M
1.91%
Sole
1.42M
Shared
0.00
None
0.00
OLEMA PHARMACEUTICALS INC
SOLEShares550K
TypeSH
Market value$5.95M
1.86%
Sole
550K
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares250.24K
TypeSH
Market value$5.88M
1.84%
Sole
250.24K
Shared
0.00
None
0.00
APELLIS PHARMACEUTICALS INC
SOLEShares135K
TypeSH
Market value$5.18M
1.62%
Sole
135K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares95K
TypeSH
Market value$5.04M
1.58%
Sole
95K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INCSOLE | COM | 90.90K | SH | $22.09M 6.92% | 90.90K | 0.00 | 0.00 |
INSMED INCSOLE | COM PAR $.01 | 265K | SH | $17.75M 5.56% | 265K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 490K | SH | $17.01M 5.33% | 490K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 300K | SH | $13.19M 4.13% | 300K | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 300K | SH | $12.24M 3.83% | 300K | 0.00 | 0.00 |
AXSOME THERAPEUTICS INCSOLE | COM | 150K | SH | $12.07M 3.78% | 150K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 86.72K | SH | $11.83M 3.70% | 86.72K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 150K | SH | $11.33M 3.55% | 150K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 240K | SH | $10.75M 3.37% | 240K | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 1M | SH | $10.57M 3.31% | 1M | 0.00 | 0.00 |
PERSPECTIVE THERAPEUTICS INCSOLE | COM NEW | 925K | SH | $9.22M 2.89% | 925K | 0.00 | 0.00 |
TG THERAPEUTICS INCSOLE | COM | 500K | SH | $8.89M 2.79% | 500K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 55K | SH | $8.69M 2.72% | 55K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 260K | SH | $8.21M 2.57% | 260K | 0.00 | 0.00 |
CORBUS PHARMACEUTICALS HLDGSSOLE | COM NEW | 175K | SH | $7.92M 2.48% | 175K | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 587.71K | SH | $7.65M 2.39% | 587.71K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 350K | SH | $7.19M 2.25% | 350K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 260K | SH | $6.86M 2.15% | 260K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 235K | SH | $6.39M 2.00% | 235K | 0.00 | 0.00 |
PHATHOM PHARMACEUTICALS INCSOLE | COM | 600K | SH | $6.18M 1.94% | 600K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM NEW | 1.42M | SH | $6.11M 1.91% | 1.42M | 0.00 | 0.00 |
OLEMA PHARMACEUTICALS INCSOLE | COM | 550K | SH | $5.95M 1.86% | 550K | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 250.24K | SH | $5.88M 1.84% | 250.24K | 0.00 | 0.00 |
APELLIS PHARMACEUTICALS INCSOLE | COM | 135K | SH | $5.18M 1.62% | 135K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 95K | SH | $5.04M 1.58% | 95K | 0.00 | 0.00 |
Page 1 of 3